Impact of body mass index on incidence of febrile neutropenia and treatment-related mortality in United States veterans with diffuse large B-cell lymphoma receiving rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone

British Journal of Haematology

Volumn 167, Issue 5, 2014, Pages 699-702

  Ganti, Arun ^a,b   Liu, Weijian ^a,c   Luo, Suhong ^a,b   Sanfilippo, Kristen M ^a,b   Roop, Ryan ^d   Lynch, Ryan ^a,b   Riedell, Peter ^a,b   O'Brian, Katiuscia ^a   Colditz, Graham A ^b   Carson, Kenneth R ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAINT LOUIS UNIVERSITY   (United States)

^d KALISPELL REGIONAL MEDICAL CENTER   (United States)

Author keywords

Diffuse large B cell lymphoma; Empiric dose reduction; Non hodgkin lymphoma; Obesity; Treatment related toxicity

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; R-CHOP PROTOCOL;

ADULT; AGED; BODY HEIGHT; BODY MASS; BODY WEIGHT; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; FEBRILE NEUTROPENIA; FEMALE; HUMAN; LARGE CELL LYMPHOMA; LETTER; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OBESITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNITED STATES; VETERAN; CHEMICALLY INDUCED; EPIDEMIOLOGY; INCIDENCE; LYMPHOMA, LARGE B-CELL, DIFFUSE; MIDDLE AGED; MORTALITY;

AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BODY MASS INDEX; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEBRILE NEUTROPENIA; FEMALE; HUMANS; INCIDENCE; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; PREDNISONE; RETROSPECTIVE STUDIES; UNITED STATES; VETERANS; VINCRISTINE;

EID: 84925225717     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13026     Document Type: Letter

References (10)

1. Bosly, A., Bron, D., Van Hoof, A., De Bock, R., Berneman, Z., Ferrant, A., Kaufman, L., Dauwe, M. & Verhoef, G. (2008) Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP. Annals of Hematology, 87, 277-283.
2. Carson, K.R., Bartlett, N.L., McDonald, J.R., Luo, S., Zeringue, A., Liu, J., Fu, Q., Chang, S.-H. & Colditz, G.A. (2012) Increased body mass index is associated with improved survival in United States veterans with diffuse large B-cell lymphoma. Journal of Clinical Oncology, 30, 3217-3222.
3. Gharib, M.I. & Burnett, A.K. (2002) Chemotherapy-induced cardiotoxicity: current practice and prospects of prophylaxis. European Journal of Heart Failure, 4, 235-242.
4. Griggs, J.J., Mangu, P.B., Anderson, H., Balaban, E.P., Dignam, J.J., Hryniuk, W.M., Morrison, V.A., Pini, T.M., Runowicz, C.D., Rosner, G.L., Shayne, M., Sparreboom, A., Sucheston, L.E. & Lyman, G.H. (2012) Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. Journal of Clinical Oncology, 30, 1-10.
5. Jepsen, P., Johnsen, S.P., Gillman, M.W. & Sørensen, H.T. (2004) Interpretation of observational studies. Heart, 90, 956-960.
6. Lyman, G.H., Dale, D.C., Friedberg, J., Crawford, J. & Fisher, R.I. (2004) Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study. Journal of Clinical Oncology, 22, 4302-4311.
7. Romano, P., Roos, L. & Jollis, J. (1993) Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. Journal of Clinical Epidemiology, 46, 1075-1090.
8. Shitara, K., Matsuo, K., Oze, I., Mizota, A., Kondo, C., Nomura, M., Yokota, T., Takahari, D., Ura, T. & Muro, K. (2011) Meta-analysis of neutropenia or leukopenia as a prognostic factor in patients with malignant disease undergoing chemotherapy. Cancer Chemotherapy and Pharmacology, 68, 301-307.
9. Sterne, J., White, I. & Carlin, J. (2009) Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. British Medical Journal, 339, 157-160.
10. WHO Expert Committee (1995) Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organization Technical Report Series, 854, 1-452.